logo
Aid funding disrupts child vaccinations almost as much as pandemic, says UN, World News

Aid funding disrupts child vaccinations almost as much as pandemic, says UN, World News

AsiaOne24-04-2025

LONDON — Global aid funding cuts, led by the United States, are disrupting efforts to vaccinate children against deadly diseases almost as much as the Covid-19 pandemic did, the United Nations said on Thursday (April 24).
Outbreaks of infectious diseases, including measles, meningitis and yellow fever, have been increasing globally.
Emergency and routine vaccinations meanwhile were significantly affected in nearly half of countries at the start of April due to the funding cuts, according to reports from World Health Organisation (WHO) offices in 108 largely low and lower-middle income countries.
Cuts to funding also reduced vaccine supplies and hampered disease surveillance, the WHO and Unicef said in a joint release with Gavi, the Vaccine Alliance.
"Setbacks (are) at a similar level to what we saw during Covid-19. We cannot afford to lose ground in the fight against preventable disease," said Catherine Russell, Unicef executive director.
Covid-19 caused what was called the largest backslide in childhood vaccination in a generation, and aid funding cuts, led by the US — formerly the world's largest donor — risked the same outcome, the joint release said.
They called for funding for childhood immunisation to be maintained ahead of Gavi's funding round, which will be launched in June. The group is seeking US$9 billion (S$12 billion) for its work from 2026 to 2030.
Sania Nishtar, Gavi's chief executive officer, said it was possible to fight the rise of infectious diseases but only if the group is fully funded.
Measles cases have increased year-on-year since 2021, while meningitis surged in Africa last year and yellow fever cases also rose after declines in the last decade, the agencies said.
Last month, an internal US government document showed it would follow its cuts to Unicef and the WHO, part of wider plans to streamline and focus foreign aid to align with the "America First" policy, by cancelling its contribution of around US$300 million annually to Gavi.
Last week, the US State Department told Reuters it had nominated Mark Lloyd, assistant administrator for global health, to Gavi's 28-person board. The US seat had previously been vacant.
Both the US State Department and Gavi declined to comment about what this could mean for US funding.
[[nid:716043]]

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Vaccine actions and policy positions under US Health Secretary Kennedy
Vaccine actions and policy positions under US Health Secretary Kennedy

Straits Times

time20 hours ago

  • Straits Times

Vaccine actions and policy positions under US Health Secretary Kennedy

FILE PHOTO: Moderna logo is seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration Vaccine actions and policy positions under US Health Secretary Kennedy U.S. Health Secretary Robert F. Kennedy Jr., a long-time vaccine skeptic, has been making sweeping changes to reshape U.S. regulation of vaccines, food and medicine. The most far-reaching of his moves culminated in the layoff of all 17 members of a U.S. Centers for Disease Control and Prevention panel of vaccine experts. Here are some of the policy moves under Kennedy's leadership in recent months, related to vaccines: FDA Recommendations for Influenza Vaccines Date of Announcement: March 13, 2025 Details: The FDA independently recommends virus strains for the 2025-2026 influenza vaccines, deviating from traditional advisory committee voting. This move assures no impact on the timing or availability of vaccines for the public. Environmental Toxin Studies Related to Autism Date of Announcement: April 16, 2025 Details: Kennedy plans studies on environmental contributors to autism, including vaccines, despite lacking scientific evidence. This approach aligns with his longstanding views on vaccines and environmental factors. Launch of US Autism Project Using Medicare and Medicaid Data Date of Announcement: May 7, 2025 Details: Federal agencies will create a database to research autism causes, focusing on Medicare and Medicaid data, as part of a broader effort to explore potential links between vaccines and autism. FDA Tightens Requirements for COVID Vaccine Date of Announcement: May 20, 2025 Details: The FDA plans new trials for annual COVID-19 boosters, limiting them to older adults and those at risk of severe illness. This change aligns with international perspectives on COVID vaccination strategies. US Drops COVID Vaccine Recommendation for Healthy Kids, Pregnant Women Date of Announcement: May 27, 2025 Details: The U.S. stops recommending routine COVID vaccinations for pregnant women and healthy children, bypassing the CDC's traditional advisory process. Cancellation of Moderna Bird Flu Vaccine Contract Date of Announcement: May 28, 2025 Details: The Trump administration cancels a contract with Moderna for the late-stage development of its bird flu vaccine, after determining it did not meet scientific standards. Moderna explores alternatives for its vaccine's development. Kennedy Guts Vaccine Advisory Committee Date of Announcement: June 9, 2025 Details: Kennedy fires all members of the CDC vaccine expert panel, which recommends how vaccines are used and by whom, promising to restore public trust in health agencies. Scientists and experts say the changes would undermine public confidence in health agencies. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.

Kennedy's firing of independent CDC advisers undermines vaccine confidence, experts say
Kennedy's firing of independent CDC advisers undermines vaccine confidence, experts say

Straits Times

timea day ago

  • Straits Times

Kennedy's firing of independent CDC advisers undermines vaccine confidence, experts say

FILE PHOTO: U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. attends a Senate Health, Education, Labor & Pensions Committee hearing on the Department of Health and Human Services budget, on Capitol Hill in Washington, D.C., U.S., May 14, 2025. REUTERS/Leah Millis CHICAGO - U.S. Health Secretary Robert F. Kennedy Jr.'s dismissal of an independent panel of experts citing the goal of restoring trust in vaccines could undermine confidence in those available now, putting Americans at risk of preventable infectious diseases, public health experts and others said on Monday. Kennedy, a longtime vaccine skeptic, said in a commentary published in the Wall Street Journal that he was firing all 17 members of the Advisory Committee for Immunization Practices (ACIP) at the Centers for Disease Control and Prevention "to re-establish public confidence in vaccine science.' The committee reviews vaccines approved by the U.S. Food and Drug Administration and makes recommendations to the CDC on their use. "I fear that there will be human lives lost here because of this," said Dr. Sean O'Leary, chair of the American Academy of Pediatrics' Committee on Infectious Diseases. "It is a special kind of irony that he is saying he is doing this to restore trust, given that he is, as an individual, more responsible for sowing distrust in vaccines than almost anyone I can name," O'Leary said. O'Leary said pediatricians have already been fielding calls from parents who are confused about conflicting announcements earlier this month narrowing the use of COVID-19 vaccines for healthy children and pregnant women. "This is only going to add to that," he said. A U.S. Department of Health and Human Services spokesman said the agency is prioritizing public health, evidence-based medicine, and restoring public confidence in vaccine science. The firing of the entire vaccine advisory committee comes just weeks before a scheduled public meeting in which advisers were expected to weigh in and vote on a number of decisions, including the 2025-26 COVID-19 vaccine boosters. The health agency said the committee will meet as scheduled on June 25-27, but it is unclear who would serve on that panel or how they have been vetted for conflicts of interest. The agency said it would replace them with new members currently under consideration. Fired ACIP member Noel Brewer, a professor of public health at the University of North Carolina, said it took about 18 months from the time he applied until he was serving as an ACIP member. Senate Minority Leader Chuck Schumer decried the changes. "Wiping out an entire panel of vaccine experts doesn't build trust — it shatters it, and worse, it sends a chilling message: that ideology matters more than evidence, and politics more than public health," he said in a statement. Former CDC Director Dr. Thomas Frieden called out Kennedy's "false claims" in the Wall Street Journal piece, saying the panel was rife with conflicts of interest. Most of the panel was appointed last year, the CDC website shows. "Make no mistake: Politicizing the ACIP as Secretary Kennedy is doing will undermine public trust under the guise of improving it." REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.

Used in Covid-19 shots, mRNA may help rid the body of HIV
Used in Covid-19 shots, mRNA may help rid the body of HIV

Straits Times

time4 days ago

  • Straits Times

Used in Covid-19 shots, mRNA may help rid the body of HIV

The new study describes the use of mRNA as a tool to flush HIV out of its hiding places. PHOTO: UNSPLASH Used in Covid-19 shots, mRNA may help rid the body of HIV NEW YORK - The technology that powered Covid-19 vaccines may also lead scientists to a cure for HIV. Using mRNA, Australian researchers said they were able to trick the virus to come out of hiding, a crucial step in ridding the body of it entirely. The research, published last week in Nature Communications, is still preliminary and so far has been shown to be successful only in a lab. But it suggests that mRNA has potential far beyond its use in vaccines as a means to deliver therapies against stubborn adversaries. Short for messenger RNA, mRNA is a set of instructions for a gene. In the case of Covid-19 vaccines, the instructions were for a piece of the coronavirus. In the new study, they are for molecules key to targeting HIV. Dr Sharon Lewin, director of the Doherty Institute at the University of Melbourne, who led the study, called mRNA a 'miraculous' tool 'to deliver things that you want into places that were not possible before.' Vaccines deploying mRNA instruct the body to produce a fragment of the virus, which then sets off the body's immune response. In the United States, the shots were initially hailed for turning back the pandemic, then viewed by some with suspicion and fear. Some officials, including Health Secretary Robert F. Kennedy Jr, have falsely said that they are highly dangerous and even deadly. Last week, the Department of Health and Human Services sought to limit the vaccine's availability to pregnant women, children and healthy younger adults. The administration also cancelled a nearly US$600 million (S$773.72 million) contract with the drugmaker Moderna to develop an mRNA shot for humans against bird flu. 'The fear right now is not rational,' Dr Lewin said, adding that 'mRNA vaccines have been given to millions of people around the world, so we have a very good understanding of their risks.' The new study describes the use of mRNA as a tool to flush HIV out of its hiding places. Other uses could involve providing proteins missing from those with certain diseases or correcting genetic errors. Dr Frauke Muecksch, a virologist at Heidelberg University in Germany who was not involved in the work, called mRNA a 'promising, absolutely powerful technology.' Although most people may have only heard of mRNA's use in science during the pandemic, scientists have been working with it for more than 20 years, she said. 'I think it's not just therapeutically very powerful, but also for basic science, for research, it opens up a lot of avenues,' she added. Potent antiretroviral drugs can now control HIV, suppressing it to undetectable levels. Still, minute amounts of the virus lie dormant in so-called reservoirs, waiting for an opportunity to resurge. A cure for HIV would involve ferreting out all of this virus and destroying it, a strategy that has been called 'shock and kill.' A significant hurdle is that the virus lies dormant in a particular type of immune cell, called a resting CD4 cell. Because these cells are inactive, they tend to be unresponsive to drugs. The few drugs scientists have previously used to rouse the virus in these cells were not specific to HIV and had unwanted side effects. 'It's fair to say the field's been a little bit stuck,' said Dr Brad Jones, a viral immunologist at Weill Cornell Medicine who was not involved in the latest research. In 2022, Dr Jones and his colleagues found that the immune boost from the mRNA vaccines awakened latent HIV in people living with the virus. (Other research has shown that mRNA vaccines also activated dormant viruses including Epstein Barr.) 'You get just a little bit of a gentle nudge with some of these vaccines, and it's enough to coax some of these latent viruses out so they can be killed,' Dr Jones said. Dr Lewin and her colleagues had for years experimented with other ways to activate HIV, but had no luck in resting cells. Seeing the success of the Covid-19 vaccines, which used lipid nanoparticles – tiny spheres of fat – containing mRNA, her team tested similar particles. They used the particles to deliver two different sets of molecules: Tat, which is adept at switching HIV on, and CRISPR, a tool that can 'edit' genes. The researchers showed that in resting immune cells from people living with HIV, the approach coaxed the virus out of dormancy. 'It's very, very hard to deal with these cells, so I think this really targeting the right population of cells is what makes this paper special,' Dr Muecksch said. It's unclear whether the new approach can successfully awaken all of the dormant HIV in the body, and what side effects it might produce. Dr Lewin said that 'mRNA will almost certainly have some adverse effects, as every drug does, but we will investigate that systematically, as we do for any new drug.' In this case, she said, side effects may be more acceptable to people living with HIV than having to take medications for the rest of their lives. The researchers plan to test the method in HIV-infected animals next, before moving into clinical trials. NYTIMES Join ST's Telegram channel and get the latest breaking news delivered to you.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store